You are on page 1of 1

Preface

When the time approached for the second edition of the clinical aspects, morphology, laboratory findings, immu-
Hematopathology book, the editors decided for a major revi- nohistochemical and flow cytometric results, cytogenetics
sion in order to make the book more useful to the read- and molecular studies, and differential diagnosis.
ers. They decided to create an Atlas of Hematopathology by This book offers important information to practicing
increasing the number of the images, whilst keeping the physicians and those in pathology and hematology train-
text concise and to the point. The most important and ing, to help them to improve their diagnostic skills. It also
unique feature of this book is that it is comprehensive and functions as a valuable referral book for researchers who
multidisciplinary: work in hematology-related areas. The book consists of 63
1. Comprehensive, because it covers both non-neoplastic hema- chapters. The first 6 chapters are devoted to normal struc-
topathology and neoplastic hematopathology in all organs ture and function of hematopoietic tissues, principles of
and tissues. immunophenotyping, cytogenetics and molecular genet-
2. Multidisciplinary, because in addition to demonstra- ics, an overview of abnormal bone marrow morphology,
tion of conventional histpathology and cytopathology, it and reactive lymphadenopathies. The remaining chapters
demonstrates results of other important complementary deal with various types of neoplastic and non-neoplastic
diagnostic tests, such as immunophenotyping (immunohis- hematopoietic disorders. The hematopoietic neoplasms
tochemical stains and flow cytometry), karyotyping, FISH and are classified according to the World Health Organization
DNA/molecular studies. (WHO) Classification published in 2008, with minor
The explosion of new molecular, cytogenetic, and pro- modifications.
teomic techniques applicable to pathology has not ren-
dered histologic examination obsolete, but rather offers Faramarz Naeim, M.D.
powerful ancillary information to facilitate differential P. Nagesh Rao, Ph.D.
diagnosis, predict prognostic behavior, and help in the
selection of targeted molecular therapies. With this in Sophie X. Song, M.D. Ph.D.
mind, we have constructed most chapters along the gen- Wayne W. Grody, M.D., Ph.D.
eral format for each disease category to demonstrate

ix

You might also like